Aethlon Medical Inc (AEMD): EBITDA
-$6.97M
Year ended 2026-03-31
-$7.93M
Trailing 12 months to 2026-09-30
| Period ended | EBITDA | Change YoY | Source filing |
|---|---|---|---|
| 2026-03-31 | -$6.97M | n/m | 2026-06-10, From 2025-04-01 |
| 2025-03-31 | -$9.00M | n/m | 2026-06-10, From 2024-04-01 |
| 2024-03-31 | -$12.28M | n/m | 2025-06-26, From 2023-04-01 |
| 2023-03-31 | -$11.66M | n/m | 2024-06-27, From 2022-04-01 |
| 2022-03-31 | -$10.30M | n/m | 2023-06-28, From 2021-04-01 |
| 2021-03-31 | -$7.85M | n/m | 2022-06-28, From 2020-04-01 |
| 2020-03-31 | -$5.90M | n/m | 2021-06-24, From 2019-04-01 |
| 2019-03-31 | -$5.97M | n/m | 2020-06-25, From 2018-04-01 |
| 2018-03-31 | -$4.80M | n/m | 2019-07-01, From 2017-04-01 |
| 2017-03-31 | -$6.07M | n/m | 2018-06-08, From 2016-04-01 |
| 2016-03-31 | -$4.35M | n/m | 2017-06-28, From 2015-04-01 |
| 2015-03-31 | -$3.96M | n/m | 2016-06-29, From 2014-04-01 |
| 2014-03-31 | -$3.03M | n/m | 2015-07-13, From 2013-04-01 |
| 2013-03-31 | -$3.56M | n/m | 2014-07-15, From 2012-04-01 |
| 2012-03-31 | -$3.10M | n/m | 2013-07-15, From 2011-04-01 |
| 2011-03-31 | -$4.54M | n/a | 2012-06-29, From 2010-04-01 |
EBITDA at similar companies
| Company | Year ended | EBITDA | Change YoY |
|---|---|---|---|
| Aethlon Medical Inc (AEMD) | 2026-03-31 | -$6.97M | n/m |
| GeoVax Labs, Inc. (GOVX) | 2025-12-31 | -$21.57M | n/m |
| Vyome Holdings, Inc (HIND) | 2025-12-31 | -$10.44M | n/m |
| OS Therapies Inc (OSTX) | 2025-12-31 | -$28.34M | n/m |
| Ernexa Therapeutics Inc. (ERNA) | 2025-12-31 | -$9.25M | n/m |
| Serina Therapeutics, Inc. (SER) | 2025-12-31 | -$23.95M | n/m |
| CV Sciences, Inc. (CVSI) | 2025-12-31 | -$278.0K | n/m |
| Cannapharmarx, Inc. (CPMD) | 2024-12-31 | -$3.63M | n/m |
| Matinas BioPharma Holdings, Inc. (MTNB) | 2025-12-31 | -$6.93M | n/m |
Compare AEMD, GOVX, HIND, OSTX side by side · Screen every company in Pharmaceutical Preparations ↗